IFCI Limited has submitted to the Exchange, the financial results for the period ended June 30, 2025.
IFCI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IFCI Limited submitted its unaudited financial results for Q1 FY26, showing a strong turnaround on the bottom line. On a standalone basis, total income rose to ₹180.86 crore from ₹123.19 crore a year ago, while profit after tax swung to ₹7.38 crore from a loss of ₹148.24 crore, driven by lower finance costs (₹102.61 cr vs ₹134.39 cr) and a ₹58.64 crore gain on fair value changes. Consolidated PAT also turned positive at ₹62.43 crore versus a loss of ₹87.17 crore. However, serious concerns remain: CRAR is deeply negative at (-)21.85% (well below RBI norms), Gross NPAs stand at an alarming 96.05%, and provisioning under RBI prudential norms exceeds Ind AS impairment by ₹85.88 crore. The government infused ₹500 crore via a preferential issue in early 2025, and an in-principle approval exists for consolidating the IFCI Group through merger/amalgamation. Auditor S Mann & Co. issued an unqualified review report but included multiple Emphasis of Matter paragraphs flagging the negative CRAR, sub-judice SHCIL litigation, valuation of subsidiaries, and a conflict-of-interest concern around the SDF scheme.
The headline swing to profit is encouraging for shareholders, but the underlying asset quality is extremely weak — 96% of loans are NPAs and capital adequacy is negative, meaning the company is technically under-capitalised relative to RBI norms. The ₹500 crore GoI infusion and ongoing group consolidation plan are key positive triggers, though execution risk remains high. Short-term stock reaction may be mixed.